Glimitip-MV 1 Forte Tablet SR
Marketer
Zodley Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimitip-MV 1 Forte Tablet SR
Glimitip-MV 1 Forte Tablet SR, an antidiabetic medication, combines multiple active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Administer this extended-release tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to identify and treat these symptoms promptly. Maintain regular mealtimes and always carry a rapid-acting glucose source, such as sweets or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor might order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimitip-MV 1 Forte Tablet SR
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Glimitip-MV 1 Forte Tablet SR
Managing type 2 diabetes
Major Benefits of Glimitip-MV 1 Forte Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimitip-MV 1 Forte Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Glimitip-MV 1 Forte Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimitip-MV 1 Forte Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimitip-MV 1 Forte Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Glimitip-MV 1 Forte Tablet SR works:
One extended-release Glimitip-MV 1 Forte tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimitip-MV 1 Forte Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitip-MV 1 Forte Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimitip-MV 1 Forte tablets may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential transfer of the medication into breast milk, with the possibility of adverse effects on the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimitip-MV 1 Forte Tablet SR is contraindicated in patients with compromised kidney function and should be avoided. Patients with severe kidney disease should not take Glimitip-MV 1 Forte Tablet SR; medical consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimitip-MV 1 Forte Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimitip-MV 1 Forte Tablet SR :
Should you forget a Glimitip-MV 1 Forte Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual medication schedule. Never take a double dose.
Facts to Know About Glimitip-MV 1 Forte Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently